References
Roberts PI, Wolfson DJ, Booth TG. The role of pharmacists in adverse drug reaction reporting. Drug Saf 1994; 11: 7–11
Kennedy DL, Tanner LA, Barash D, et al. National adverse drug event reporting. Am J Hosp Pharm 1993; 50: 1913–4
Henahan S. Unexpected fate for felbamate. Inpharma 1994; 950: 3
Kessler DA. MED Watch: the new FDA medical products reporting program. Am J Hosp Pharm 1993; 50: 1151–2
British National Formulary 1994; 27: 10
Chen RT, Rastogi SC, Mullen JR, et al. The vaccine adverse event reporting system. Vaccine 1994; 12: 542–50
New Ethicals Catalogue: 8, Apr 1994
American Society of Hospital Pharmacists. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Hosp Pharm 1989; 46: 336–337
Chrisp P. FDA and ASHP collaborate on serious ADR reporting. Reactions 1993; 456: 4
Stoukides CA, D’Agostino PR, Kaufman MB. Adverse drug reaction surveillance in an emergency room. Am J Hosp Pharm 1993; 50: 712–4
Adamcik BA, Rhodes RS. The pharmacist’s role in rational drug therapy of the aged. Drugs Aging 1993; 3: 481–6
Raymond PM, Robertson MB. Adverse drug reaction reporting in Melbourne teaching hospitals. Aust J Hosp Pharm 1994; 24: 237–42
Hospital pharmacists increase yellow card reporting. Pharm J 1993; 251: 426
Wolfson DJ, Booth TG, Roberts PI. The community pharmacist and adverse drug reaction monitoring (2) An Examination of the potential role in the United Kingdom. Pharm J 1993; 251: 21–4
American Society of Hospital Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm 1993; 50: 305–14
Mandatory reporting of medication errors that result in death. FDC Reports — The Pink Sheet 1993 Dec 13; 55: T&G5-6
Edgar TA, Lee DS, Cousins DD. Experience with a national medication error reporting program. Am J Hosp Pharm 1994; 51: 1335–8
Rights and permissions
About this article
Cite this article
Pharmacists have a major role in ADR and medication error monitoring and reporting. Drugs Ther. Perspect 5, 10–11 (1995). https://doi.org/10.2165/00042310-199505010-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199505010-00004